Video

Debunking Clinical Trial Myths

Many patients with ovarian cancer have misconceptions about the care they will receive while on a clinical trial, according to Laurel W. Rice, M.D.

Clinical trials lead to new advancements in ovarian cancer, but many patients may be apprehensive to go on them. So, it is crucial that they understand what a trial is all about, according to Laurel W. Rice, M.D., chair of the Department of Obstetrics and Gynecology and a professor in the Division of Gynecologic Oncology at the University of Wisconsin-Madison School of Medicine and Public Health, and president of the Society for Gynecologic Oncology (SGO).

While some trials do include an arm of patients who receive a placebo, many more actually compare an investigative medicine versus a standard-of-care treatment, so all participants are getting treated. SGO was involved in developing an easy-to-understand video that helps patients better understand clinical trials.

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with brown and grey hair.
Image of man with grey hair.
Image of bald man in suit.
Related Content